Span-85

CAS No. 26266-58-0

Span-85 ( Sorbitan trioleate )

Catalog No. M28740 CAS No. 26266-58-0

Span is a synthetic non-ionic emulsifier, which is prepared by partial esterification of sorbitol or sorbitan with food grade palmitic acid.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 49 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Span-85
  • Note
    Research use only, not for human use.
  • Brief Description
    Span is a synthetic non-ionic emulsifier, which is prepared by partial esterification of sorbitol or sorbitan with food grade palmitic acid.
  • Description
    Span is a synthetic non-ionic emulsifier, which is prepared by partial esterification of sorbitol or sorbitan with food grade palmitic acid. It has low viscosity and the smallest HLB value, so it has the strongest lipophilicity. It is an excellent water-in-oil (w/O) emulsifier and an O/w type auxiliary emulsifier.
  • Synonyms
    Sorbitan trioleate
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    nAChR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    26266-58-0
  • Formula Weight
    957.5
  • Molecular Formula
    C60H108O8
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CCCCCCCC\C=C/CCCCCCCC(=O)O[C@H](CO)[C@H]1OC[C@H](OC(=O)CCCCCCC\C=C/CCCCCCCC)[C@H]1OC(=O)CCCCCCC\C=C/CCCCCCCC
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Smith AM, et al. Repeated nicotine administration robustly increases bPiDDB inhibitory potency at alpha6beta2-containing nicotinic receptors mediating nicotine-evoked dopamine release. Biochem Pharmacol. 2010 Aug 1;80(3):402-9.
molnova catalog
related products
  • Eupatorin

    Eupatorin has antiproliferative and antiangiogenic effects. Eupatorin has antiproliferative and cytostatic effects on MDA-MB-468 human breast cancer cells due to CYP1-mediated metabolism.

  • Ribostamycin sulfate

    Ribostamycin is a broad-spectrum antimicrobial, inhibits bacterial protein synthesis at the level of 30S and 50S ribosomal subunit binding, also inhibits the chaperone activity of protein disulfide isomerase (PDI), used in pharmacokinetic and nephrotoxicity studies.

  • UBP 310

    GLUK5 kainate receptor antagonist.